期刊
AGING CELL
卷 13, 期 5, 页码 787-796出版社
WILEY
DOI: 10.1111/acel.12220
关键词
healthspan; inflammation; lifespan; muscle wasting; osteoporosis; sirtuins
资金
- National Medical Health and Research Council of Australia [RGMS ID 2010-01671]
- NIH [RO1 AR56679]
- Intramural Research Program of the NIA/NIH
- Glenn Foundation for Medical Research
- JDRF UMDF, R01 [AG028730]
Increased expression of SIRT1 extends the lifespan of lower organisms and delays the onset of age-related diseases in mammals. Here, we show that SRT2104, a synthetic small molecule activator of SIRT1, extends both mean and maximal lifespan of mice fed a standard diet. This is accompanied by improvements in health, including enhanced motor coordination, performance, bone mineral density, and insulin sensitivity associated with higher mitochondrial content and decreased inflammation. Short-term SRT2104 treatment preserves bone and muscle mass in an experimental model of atrophy. These results demonstrate it is possible to design a small molecule that can slow aging and delay multiple age-related diseases in mammals, supporting the therapeutic potential of SIRT1 activators in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据